Microscopic Papillary Thyroid Carcinoma Compared With Clinical Carcinomas by Loss of Heterozygosity Mutational Profile
- 1 February 2003
- journal article
- research article
- Published by Wolters Kluwer Health in The American Journal of Surgical Pathology
- Vol. 27 (2) , 159-166
- https://doi.org/10.1097/00000478-200302000-00003
Abstract
The clinical significance of microscopic papillary thyroid carcinoma (PTCa) is controversial. Many authors think that microscopic PTCa (1 cm). Despite the fact that all clinical risk prognostication schemes have the size of the tumor as a primary category, small tumors do have malignant potential and can metastasize. There is growing evidence that small PTCa have the molecular translocations between the proto-oncogene RET and various activating partner genes that are characteristic of clinically sized PTCa. This study used a microdissection and genotyping assay to study the patterns of loss of heterozygosity of tumor suppressor genes in microscopic and clinically sized PTCa. Our results indicate that all PTCa harbor mutations with similar frequencies and distribution patterns, regardless of the size of the tumor. These data are further evidence that microscopic and clinically sized PTCa are pathogenetically related.Keywords
This publication has 22 references indexed in Scilit:
- Analysis of ret/PTC Gene Rearrangements Refines the Fine Needle Aspiration Diagnosis of Thyroid CancerJournal of Clinical Endocrinology & Metabolism, 2001
- Thyroid cancerCancer Letters, 2001
- ret/PTC-1 Activation in Hashimoto ThyroiditisInternational Journal of Surgical Pathology, 2000
- Characteristics of thyroid carcinomas in aging patientsEuropean Journal of Clinical Investigation, 2000
- An Overview of the Management of Papillary and Follicular Thyroid CarcinomaThyroid®, 1999
- Symptomatic versus Asymptomatic Papillary Thyroid Microcarcinoma: A Retrospective Analysis of Surgical Outcome and Prognostic Factors.Endocrine Journal, 1999
- Unilateral total lobectomy: Is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma?Surgery, 1998
- Distinct Multiple RET/PTC Gene Rearrangements in Multifocal Papillary Thyroid NeoplasiaJournal of Clinical Endocrinology & Metabolism, 1998
- Our ames is true: How an old concept still hits the mark: or, risk group assignment points the arrow to rational therapy selection in differentiated thyroid cancerThe American Journal of Surgery, 1997
- Expression of the RET/PTC Fusion Gene as a Marker for Papillary Carcinoma in Hashimoto's ThyroiditisThe Laryngoscope, 1997